These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24347431)

  • 61. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard.
    Casbohm SL; Rogers JV; Stonerock MK; Martin JL; Ricketts-Kaminsky KM; Babin MC; Casillas RP; Sabourin CL
    Toxicology; 2004 Nov; 204(2-3):229-39. PubMed ID: 15388249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons.
    Xu JH; Hu HT; Liu Y; Qian YH; Liu ZH; Tan QR; Zhang ZJ
    Neurosci Lett; 2006 May; 399(3):210-4. PubMed ID: 16513270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
    Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    DeNeve WJ; Everett CK; Suminski JE; Valeriote FA
    Cancer Res; 1988 Nov; 48(21):6002-5. PubMed ID: 2844397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The early research and development of ebselen.
    Parnham MJ; Sies H
    Biochem Pharmacol; 2013 Nov; 86(9):1248-53. PubMed ID: 24012716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Defining the timing of 25(OH)D rescue following nitrogen mustard exposure.
    Das LM; Binko AM; Traylor ZP; Duesler L; Lu KQ
    Cutan Ocul Toxicol; 2018 Jun; 37(2):127-132. PubMed ID: 28737434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard.
    Sunil VR; Patel KJ; Shen J; Reimer D; Gow AJ; Laskin JD; Laskin DL
    Toxicol Appl Pharmacol; 2011 Jan; 250(1):10-8. PubMed ID: 20883710
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model.
    Goswami DG; Mishra N; Kant R; Agarwal C; Ammar DA; Petrash JM; Tewari-Singh N; Agarwal R
    Toxicol Appl Pharmacol; 2022 Feb; 437():115904. PubMed ID: 35108561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nitrogen mustard- and half-mustard-induced damage in Escherichia coli requires different DNA repair pathways.
    De Alencar TA; Leitão AC; Lage C
    Mutat Res; 2005 Apr; 582(1-2):105-15. PubMed ID: 15781216
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro neurotoxic and DNA-damaging properties of nitrogen mustard.
    Kisby GE; Springer N; Spencer PS
    J Appl Toxicol; 2000 Dec; 20 Suppl 1():S35-41. PubMed ID: 11428641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nitrogen mustard-mediated mutagenesis in human T-lymphocytes in vitro.
    Olsen LS; Korsholm B; Nexø BA; Wassermann K
    Arch Toxicol; 1997; 71(3):198-201. PubMed ID: 9049058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protective effect of thiosulfate and metabolic thiosulfate precursors against toxicity of nitrogen mustard (HN2).
    Fasth A; Sörbo B
    Biochem Pharmacol; 1973 Jun; 22(11):1337-51. PubMed ID: 4727786
    [No Abstract]   [Full Text] [Related]  

  • 73. Differential effect of IP- and IV-injected nitrogen mustard on subsequently-irradiated intestinal crypts: implications for 'dose-effect factors' predicted by experimental, combined modality therapy.
    Moore JV
    Br J Radiol; 1984 May; 57(677):403-7. PubMed ID: 6722435
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea.
    Goswami DG; Kant R; Tewari-Singh N; Agarwal R
    Toxicol Lett; 2018 Sep; 293():127-132. PubMed ID: 29174984
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes.
    Jan YH; Heck DE; An Y; Laskin DL; Laskin JD
    Chem Res Toxicol; 2022 Apr; 35(4):636-650. PubMed ID: 35312310
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Corneal toxicity induced by vesicating agents and effective treatment options.
    Goswami DG; Tewari-Singh N; Agarwal R
    Ann N Y Acad Sci; 2016 Jun; 1374(1):193-201. PubMed ID: 27327041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potentiation of nitrogen mustard cytotoxicity to leukemia cells by sulfur-containing compounds administered in vivo.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1165-9. PubMed ID: 3744935
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clastogenic effects of transplacental exposure of mouse embryos to nitrogen mustard or cyclophosphamide.
    Meyne J; Legator MS
    Teratog Carcinog Mutagen; 1983; 3(3):281-7. PubMed ID: 6137084
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential effects of nitrogen mustard in vivo on the cancer and host cells in MCa-11 tumours.
    Bose KK; Zahurak ML; Allison DC
    Cell Prolif; 1995 Jul; 28(7):403-14. PubMed ID: 7548441
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trial.
    Hartmann DW; Robinson WA; Morton NJ; Mangalik A; Glode LM
    Blut; 1981 Apr; 42(4):209-20. PubMed ID: 7013856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.